Policy makers and businesses across the globe are struggling to determine when and how to return to normalcy, balancing health safety with economic pressures and needs. And while most are focusing on susceptibility, case count, deaths and recovery rates one critical piece of information is noticeably missing from the equation - re-emergence. Can individuals get re-infected? Does the virus remain dormant? Can they once again become infectious? A 16% relapse rate suggests we should bee considering it.